Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-07-31
2007-07-31
McKane, Joseph K. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S250000
Reexamination Certificate
active
10795760
ABSTRACT:
This invention relates to novel tetrazole and oxadiazalone β-amino acids derivatives of the formulawherein G iswherein R1through R4are defined as in the specification, pharmaceutical compositions containing them and their use for the treatment of various central nervous system and other disorders. The cyclopropyl β-amino acids derivatives of this invention exhibit activity as alpha2delta ligands (α2δ ligands). Such compounds have affinity for the α2δ subunit of a calcium channel.
REFERENCES:
patent: 4024175 (1977-05-01), Satzinger et al.
patent: 4087544 (1978-05-01), Satzinger et al.
patent: 5563175 (1996-10-01), Silverman et al.
patent: 6316638 (2001-11-01), Bryans et al.
patent: 2003/0176504 (2003-09-01), Dooley et al.
patent: WO 99/08671 (1999-02-01), None
patent: WO 99/31057 (1999-06-01), None
patent: WO 99/31074 (1999-06-01), None
patent: WO 99/31075 (1999-06-01), None
patent: WO 99/61424 (1999-12-01), None
patent: WO 00/15611 (2000-03-01), None
C. Ainsworth, 5-β-aminoethyltetrazole, J.A.C.S., vol. 75, pp. 5728-5729 (1953).
Sluka et al., Muscle & Nerve, vol. 24, pp. 37-46, 2001 and Vogel et al., Psychopharmacologia, vol. 21, pp. 1-7, 1971.
Leonard et al., “Centrall Active 2-(Substituted phenyl)-β-alanines,” J. Org. Chem., 1961, vol. 26, pp. 4062-4065.
See Patani et al., “Bioisosterism: A Rational Approach in Drug Design,” Chem. Rev. 1996, vol. 96, pp. 3147-3176.
C. Ainsworth, (J.A.C.S., vol. 75, pp. 5728-5729 (1953)).
Sluka et al., Muscle & Nerve, vol. 24, pp. 37-46, 2001.
Vogel et al., Psychopharmacologia, vol. 21, pp. 1-7, 1971.
Vogel, J.R., et al., “A Simple and Reliable Conflict Proceedure for Testing Anti-Anxiety Agents”, Psychopharmacologia, (1971), pp. 1-7, vol. 21.
Berge S.M., et al., “Pharamaceutical Salts”, J. of Pharma Sci, (1977), pp. 1-19, vol. 66:1.
Palomino E., Delivery of Drugs Through Dihydropyridine Carriers, Drugs of the Future, (1990), pp. 361-368, vol. 15(4).
Gee, N.S., et al., The Novel Anticonvulsant Drug, Gabapentin (Neurontin), Binds to the a2d Subunit of a Calcium Channel, J. Biol. Chem., (1996) pp. 5768-5776, vol. 271(10).
Sluka, K., et al., “Unilateral Intramuscular Injections of Acidic Saline Produce A Bilateral, Long-Lasting Hyperalgesia”, Muscle & Nerve, (2001), pp. 37-46, vol 24.
Dixon, W., “Efficient analysis of experimental observations”, Ann Rev Pharmacol Toxicol, (1980), pp. 441-462, vol. 20.
Randall, L.O & Selitto, J.J., “A Method For Measurement of Analgesic Activity On Inflamed Tissue”, Arch. Int. Pharmacodyn, (1957), pp. 409-419, vol. 4.
McManus, J.M., et al., “Tetrazole Analogs of Amino Acids”, J Org Chem, 1959, pp. 1643-1649, vol. 24.
Hargreaves, K, et al., “A New Sensitive Method for Measuring Thermal Nociception in Cutaneous Hyperalgesia”, Pain, (1988), pp. 77-88, vol. 32.
Barta Nancy Sue
Colbry Norman Lloyd
Hudack, Jr. Raymond
Lin Kristin Knapp
Schwarz Jacob Bradley
Ashbrook Charles W.
Chung Susannah L.
DeBenedictis Karen
Harvey Suzanne M.
McKane Joseph K.
LandOfFree
Tetrazole and oxadiazolone substituted β-amino acid... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tetrazole and oxadiazolone substituted β-amino acid..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tetrazole and oxadiazolone substituted β-amino acid... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3741107